Basil Pesto Bowtie Pasta Salad, UPC 294921 #####. Product was made in-store with store generated scale label applied to the container. ...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0118-2026.
Listeria monocytogenes. Albertson's store-made deli items contain a recalled bowtie pasta ingredient which was recalled due to Listeria monocytogenes.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0118-2026.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Albertsons Companies Llc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0118-2026.
Albertsons Companies LLC
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Albertsons Companies Llc Recall FAQ
Albertsons Companies Llc is the subject of a produce safety report: Basil Pesto Bowtie Pasta Salad, UPC 294921 #####. Product was made in-store with store generated scale label applied to the container. .... The notice was published on September 26, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.